Xunsheng Biomedical

Xunsheng Biomedical

循生医学

Xunsheng Biomedical

Biotech/Healthcare

Xunsheng Medicine is an innovative biopharmaceutical company focused on cancer immunotherapy research. It develops biotechnology for tumor immunology drugs and novel personalized cancer immunotherapies, including immune cell therapies and therapeutic cancer vaccines such as cervical cancer vaccines.

Latest round: Series B Extension+ (2026)

Source: ChinaBulls — chinabulls.com

Last updated 2026-10-01

Funding history

Request access to view this section.

Investors

Request access to view this section.

HQ & website

Request access to view this section.

Tags

Request access to view this section.